Evaluation of the updated French Autorisation d’accès précoce (AAP) Early Access Authorisation pathway

Previous PostA review and evaluation of the UK's Innovative Licensing and Access Pathway
Next PostModified Delphi research to seek consensus on dRTA disease model, treatment and management